Trial intelligence / Profile preview

VD vs VTD Induction in Newly Diagnosed Multiple Myeloma

NCT00910897Phase 3Unknown

Start
Mar 2008
Primary completion
Aug 2009
Modality
Small Molecules
Countries
2
01

Overview

A Phase 3 trial of thalidomide in multiple myeloma (MM). Status: unknown.

02

Drugs

thalidomide
03

Conditions

multiple myeloma (MM)

Beyond the preview

Go deeper on NCT00910897.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00910897.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call